
Company Number
06550769
Next Accounts
Sep 2025
Shareholders
united biosource llc
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
12 new fetter lane, london, EC4A 1JP
Website
ubc.comPomanda estimates the enterprise value of UNITED BIOSOURCE HOLDING (UK) LIMITED at £0 based on a Turnover of £0 and 1.17x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of UNITED BIOSOURCE HOLDING (UK) LIMITED at £0 based on an EBITDA of £0 and a 4.66x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of UNITED BIOSOURCE HOLDING (UK) LIMITED at £211k based on Net Assets of £132.5k and 1.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
United Biosource Holding (uk) Limited is a live company located in london, EC4A 1JP with a Companies House number of 06550769. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in April 2008, it's largest shareholder is united biosource llc with a 100% stake. United Biosource Holding (uk) Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Pomanda's financial health check has awarded United Biosource Holding (Uk) Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 2 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (13.1%)
- United Biosource Holding (uk) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Employees
with 3 employees, this is below the industry average (54)
- - United Biosource Holding (uk) Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - United Biosource Holding (uk) Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 56.1%, this is a similar level of debt than the average (53.1%)
- - United Biosource Holding (uk) Limited
- - Industry AVG
United Biosource Holding (Uk) Limited's latest turnover from December 2023 is 0 and the company has net assets of £132.5 thousand. According to their latest financial statements, United Biosource Holding (Uk) Limited has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 11,747,900 | 10,510,648 | |||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 7,203,809 | 7,800,690 | |||||||||||||
Gross Profit | 4,544,091 | 2,709,958 | |||||||||||||
Admin Expenses | 3,634,523 | -29,138,422 | |||||||||||||
Operating Profit | 909,568 | 31,848,380 | -135,376 | -256,656 | -3,027,304 | -361,694 | -358,850 | -504,125 | -323,197 | ||||||
Interest Payable | 24,745 | 6,386,492 | 5,589,670 | 4,791,072 | 4,157,921 | 3,260,073 | 520,450 | 364,842 | |||||||
Interest Receivable | 664 | 5,390 | 3,730 | ||||||||||||
Pre-Tax Profit | 884,823 | 31,848,380 | -6,521,868 | -5,846,326 | -3,231,914 | -25,838,331 | -3,618,923 | -1,019,185 | -684,308 | ||||||
Tax | -365,177 | -193,461 | -435,882 | 60,766 | -145,110 | ||||||||||
Profit After Tax | 519,646 | 31,654,919 | -6,957,751 | -5,785,560 | -3,231,914 | -25,838,331 | -3,618,923 | -1,164,295 | -684,308 | ||||||
Dividends Paid | |||||||||||||||
Retained Profit | 519,646 | 31,654,919 | -6,957,751 | -5,785,560 | -3,231,914 | -25,838,331 | -3,618,923 | -1,164,295 | -684,308 | ||||||
Employee Costs | 6,959,358 | 8,105,129 | |||||||||||||
Number Of Employees | 3 | 3 | 2 | 3 | 103 | 106 | 3 | ||||||||
EBITDA* | 975,555 | 31,979,604 | -20,827 | -71,960 | -2,873,846 | -219,265 | -217,297 | -504,125 | -323,197 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 58,488 | 125,224 | 123,131 | 255,098 | 384,182 | 524,616 | 642,895 | ||||||||
Intangible Assets | |||||||||||||||
Investments & Other | 5,299 | 5,299 | 5,642 | 5,297 | 5,025 | 5,327 | 5,207 | 5,597 | 5,315 | 59,747,001 | 80,749,364 | 61,924,288 | 36,408,598 | ||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 5,299 | 5,299 | 5,642 | 5,297 | 5,025 | 5,327 | 58,488 | 125,225 | 5,207 | 128,728 | 260,413 | 60,131,184 | 81,273,980 | 62,567,184 | 36,408,598 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 49,490 | ||||||||||||||
Group Debtors | 296,722 | 296,722 | 11,139,772 | 7,520,995 | 74,698,750 | 80,295,034 | 66,714,940 | 1,051,476 | |||||||
Misc Debtors | 337,739 | 317,063 | 300,789 | 318,873 | 2,566,736 | 2,060,587 | 388,277 | 413,368 | 279,014 | 262,368 | 260,756 | 273,386 | 145,109 | ||
Cash | 2,955,159 | 5,496,401 | |||||||||||||
misc current assets | |||||||||||||||
total current assets | 296,722 | 296,722 | 337,740 | 317,064 | 300,790 | 318,874 | 16,711,158 | 15,077,984 | 75,087,028 | 80,708,403 | 66,993,955 | 262,369 | 260,756 | 273,387 | 1,196,586 |
total assets | 302,021 | 302,021 | 343,382 | 322,361 | 305,815 | 324,201 | 16,769,646 | 15,203,209 | 75,092,234 | 80,837,131 | 67,254,368 | 60,393,553 | 81,534,736 | 62,840,570 | 37,605,184 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 259,448 | 415,417 | |||||||||||||
Group/Directors Accounts | 169,556 | 169,556 | 180,558 | 169,504 | 160,804 | 170,472 | 9,368,626 | 8,652,519 | 106,628,979 | 52,595,347 | 39,031,422 | 30,540,355 | 9,213,385 | 11,248,346 | 9,489,397 |
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 21,763 | 20,431 | 19,382 | 20,547 | 608,128 | 752,099 | 532,579 | 77,556 | 15,279 | 14,367 | 58,980 | 44,275 | 37,158 | ||
total current liabilities | 169,556 | 169,556 | 202,321 | 189,936 | 180,187 | 191,020 | 10,236,203 | 9,820,036 | 107,161,559 | 52,672,903 | 39,046,702 | 30,554,723 | 9,272,366 | 11,292,622 | 9,526,555 |
loans | 55,157,112 | 45,828,074 | 43,094,077 | 33,304,503 | 8,328,528 | ||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 50,900,229 | ||||||||||||||
provisions | 274,862 | 9,129,570 | 1,886,149 | 12,479,006 | |||||||||||
total long term liabilities | 55,157,112 | 45,828,074 | 43,368,941 | 60,029,801 | 35,190,653 | 20,807,535 | |||||||||
total liabilities | 169,556 | 169,556 | 202,321 | 189,936 | 180,187 | 191,020 | 10,236,203 | 9,820,036 | 107,161,559 | 107,830,015 | 84,874,776 | 73,923,663 | 69,302,167 | 46,483,275 | 30,334,090 |
net assets | 132,465 | 132,465 | 141,061 | 132,425 | 125,628 | 133,181 | 6,533,443 | 5,383,173 | -32,069,325 | -26,992,884 | -17,620,408 | -13,530,110 | 12,232,570 | 16,357,295 | 7,271,094 |
total shareholders funds | 132,465 | 132,465 | 141,061 | 132,425 | 125,628 | 133,181 | 6,533,443 | 5,383,173 | -32,069,325 | -26,992,884 | -17,620,408 | -13,530,110 | 12,232,570 | 16,357,295 | 7,271,094 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 909,568 | 31,848,380 | -135,376 | -256,656 | -3,027,304 | -361,694 | -358,850 | -504,125 | -323,197 | ||||||
Depreciation | 65,987 | 131,224 | 114,549 | 184,697 | 153,458 | 142,429 | 141,553 | ||||||||
Amortisation | |||||||||||||||
Tax | -365,177 | -193,461 | -435,882 | 60,766 | -145,110 | ||||||||||
Stock | |||||||||||||||
Debtors | -41,017 | 20,676 | 16,274 | -18,084 | -13,437,125 | 4,174,415 | -65,505,444 | -5,621,376 | 13,714,449 | 66,731,586 | 1,612 | -12,630 | -923,199 | 1,196,585 | |
Creditors | -259,448 | -155,969 | 415,417 | ||||||||||||
Accruals and Deferred Income | -21,763 | 1,332 | 1,049 | -1,165 | -587,581 | -143,971 | 219,520 | 455,023 | 62,277 | 912 | -44,613 | 14,705 | 7,117 | 37,158 | |
Deferred Taxes & Provisions | -274,862 | -8,854,708 | 7,243,421 | -10,592,857 | 12,479,006 | ||||||||||
Cash flow from operations | 19,254 | 16,919 | 12,590,096 | -3,863,977 | 97,926,524 | 5,619,690 | -13,663,365 | -69,879,382 | -9,120,198 | 7,053,459 | |||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | -344 | 345 | 272 | -302 | 5,327 | -5,207 | -390 | 282 | -59,741,687 | -21,002,362 | 18,825,076 | 25,515,690 | 36,408,598 | ||
cash flow from investments | 5,207 | ||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -11,002 | 11,053 | 8,700 | -9,668 | -9,198,154 | 716,107 | -97,976,460 | 54,033,633 | 13,563,924 | 8,491,067 | 21,326,969 | -2,034,961 | 1,758,949 | 9,489,397 | |
Other Short Term Loans | |||||||||||||||
Long term loans | -55,157,112 | 9,329,038 | 2,733,997 | 43,094,077 | -33,304,503 | 24,975,975 | 8,328,528 | ||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | -50,900,229 | 50,900,229 | |||||||||||||
share issue | |||||||||||||||
interest | -24,745 | -6,386,492 | -5,589,670 | -4,790,408 | -4,157,921 | -3,260,073 | -515,060 | -361,112 | |||||||
cash flow from financing | -19,597 | -17,221 | -15,598,416 | 1,321,986 | -92,178,881 | -5,628,661 | 13,716,376 | 5,576,272 | 9,438,547 | 11,794,890 | 36,470,361 | 25,412,215 | |||
cash and cash equivalents | |||||||||||||||
cash | -2,955,159 | -2,541,242 | 5,496,401 | ||||||||||||
overdraft | |||||||||||||||
change in cash | -2,955,159 | -2,541,242 | 5,496,401 |
Perform a competitor analysis for united biosource holding (uk) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in EC4A area or any other competitors across 12 key performance metrics.
UNITED BIOSOURCE HOLDING (UK) LIMITED group structure
United Biosource Holding (Uk) Limited has 1 subsidiary company.
Ultimate parent company
AVISTA CAPITAL PARTNERS LP
#0109618
ACP ULYSSES HOLDINGS INC
#0036413
2 parents
UNITED BIOSOURCE HOLDING (UK) LIMITED
06550769
1 subsidiary
United Biosource Holding (Uk) Limited currently has 3 directors. The longest serving directors include Mrs Karen Turner (Jan 2023) and Ms Rebeka Brown (Jan 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Karen Turner | United Kingdom | 57 years | Jan 2023 | - | Director |
Ms Rebeka Brown | United Kingdom | 49 years | Jan 2023 | - | Director |
Mr Michael Haratz | United Kingdom | 64 years | Jan 2023 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
132.5k
0%
total assets
302k
0%
cash
0
0%
net assets
Total assets minus all liabilities
company number
06550769
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
April 2008
age
17
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
MOORE KINGSTON SMITH LLP
address
12 new fetter lane, london, EC4A 1JP
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to united biosource holding (uk) limited. Currently there are 0 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for UNITED BIOSOURCE HOLDING (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|